Comparison · NCT04040296-dc1cc11d
Kidney Action Team Recommendations vs Usual Care: Composite Outcome Showing the Percentage of Participants With Any One of the Following: Progression of AKI, Inpatient Dialysis, or Inpatient Death
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Kidney Action Team Recommendations vs Usual Care: Composite Outcome Showing the Percentage of Participants With Any One of the Following: Progression of AKI, Inpatient Dialysis, or Inpatient Death. Trial comparisons, record NCT04040296-dc1cc11d. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04040296-dc1cc11d
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.198 | 0.181 | 0.216 | wilson | |
| Risk in group 2 | 0.184 | 0.168 | 0.202 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0135 | -0.0109 | 0.0378 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.07 | 0.945 | 1.22 | log | |
| Odds ratio, group 1 over group 2 | 1.09 | 0.932 | 1.28 | log | |
| Number needed to treat, for one more participant with the outcome on Kidney Action Team Recommendations than on Usual Care | 74.3 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: usual care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Kidney Action Team Recommendations | Recommendations made by the Kidney Action Team will be delivered to the patient's primary care team within 2 hours of AKI detection.~Kidney Action Team Recommendations: Upon review of the patient's medical information, the Kidney Action Team will create personalized recommendations that will be delivered to the patient's primary care team via a specialized note in the electronic medical record system within 2 hours of AKI detection. The attending of record will be identified as a cosigner to ensure that a member of the care team is made aware of the note's presence. | 395 | 1,999 | OG001 |
| Group 2 | Usual Care | Kidney Action Team Recommendations will not be delivered to the primary care teams of randomized patients. | 369 | 2,004 | OG000 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Composite Outcome Showing the Percentage of Participants With Any One of the Following: Progression of AKI, Inpatient Dialysis, or Inpatient Death
- Description
Progression of AKI is defined by an increase in KDIGO creatinine stage from that present at the time of randomization.~Dialysis is defined by the receipt of hemodialysis, continuous renal replacement therapy or peritoneal dialysis. Isolated ultrafiltration treatments (for the purpose of volume removal) will not be included.~Mortality will be determined from hospital administrative records.~The rates of the primary outcome will be compared between the study arms using the Cochrane-Mantel-Haenszel chi-square test, accounting for stratification by hospital.
- Time frame
- 14 days post randomization or at hospital discharge, whichever comes first
- Population
Source ClinicalTrials.gov
Trial
- Title
- Personalized Recommendations for Acute Kidney Injury (AKI) Care
- NCT number
- NCT04040296
- Phases
- NA
- Conditions
- Acute Kidney Injury
- Interventions
- Kidney Action Team Recommendations
- Lead sponsor
- Yale University
- Results first posted
- 2025-07-17
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT04040296?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT04040296-dc1cc11d